Analystreport

Prometheus Biosciences, Inc. (NASDAQ: RXDX) was upgraded by analysts at Oppenheimer Holdings Inc. to an "outperform" rating. They now have a $50.00 price target on

Prometheus Biosciences, Inc.  (RXDX) 
Last prometheus biosciences, inc. earnings: 11/7 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ignyta.com